To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

Mise à jour : Il y a 4 ans
Référence : NCT02326155

Femme et Homme

Extrait

An observational, prospective cohort study to evaluate the safety and efficacy of Remsima™ in patients with Crohn's disease (CD) or Ulcerative Colitis (UC)


Critère d'inclusion

  • Crohn’s Disease ,Ulcerative colitis

Liens